Belgium· BE-AMP-SAM661771-00
Abrysvo
A respiratorisches-synzytial-virus impfstoffe product containing recombinant respiratory syncytial virus, subgroup a, stabilised prefusion f protein 847a, registered in Belgium by Pfizer Europe MA. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Recombinant Respiratory Syncytial Virus, Subgroup A, Stabilised Prefusion F Protein 847A
- Manufacturer
- Pfizer Europe MA
- Country
- Belgium (BE)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb4736807EUR 186.36
- be_apb7742299
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2252151-4936-41c2-a28c-4e4017924eca GET /v1/drugs/a2252151-4936-41c2-a28c-4e4017924eca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Abrysvo",
"name_fr": "Abrysvo",
"name_nl": "Abrysvo",
"amp_code": "SAM661771-00",
"strengths": [
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"60.0000",
"0.0800"
],
"pack_count": 8,
"substances": [
"Recombinant Respiratory Syncytial Virus, Subgroup A, Stabilised Prefusion F Protein 847A",
"Recombinant Respiratory Syncytial Virus, Subgroup B, Stabilised Prefusion F Protein 847B",
"Mannitol",
"Sodium Chloride",
"Sucrose",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Respiratory Syncytial Virus Vaccines",
"authorisation_numbers": [
"EU/1/23/1752/006",
"EU/1/23/1752/002",
"EU/1/23/1752/004",
"EU/1/23/1752/001",
"EU/1/23/1752/005",
"EU/1/23/1752/003",
"EU/1/23/1752/007",
"EU/1/23/1752/008"
]
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.